64 - “Stratification of patients with spine metastases at high risk of fracture: from biomechanical analyses in the laboratory to an in silico clinical tool”
In this webinar the speaker will present the development of an in silico clinical tool designed to identify patients with spinal metastases at high risk of fracture. The session will trace the translational pathway from biomechanical analyses conducted in the laboratory to the creation of a clinically deployable, patient-specific simulation platform. This innovative approach supports clinicians in stratifying patients based on fracture risk, improving treatment decision-making and patient outcomes. The presentation will explore the computational modelling techniques, the integration of clinical data, and the validation process needed to ensure reliability and clinical relevance. Attendees will gain a deeper understanding of how in silico methods can enhance personalized spine oncology care and contribute to safer, more targeted interventions for patients with metastatic spinal disease.
